Table: Sapporo Clinical Lab -Q1 group results

Sapporo Clinical Laboratory

04/08/2025 07:31

Aug 4 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             5.07                5.00             20.69    
                 (+1.4 pct)          (+1.6 pct)       (+2.8 pct)  
  Operating        87 mln              98 mln           775 mln   
                 (-10.9 pct)         (+30.3 pct)      (+9.9 pct)  
  Recurring        93 mln              102 mln          771 mln   
                 (-8.4 pct)          (+26.5 pct)      (+8.9 pct)  
  Net              47 mln              56 mln           505 mln   
                 (-15.4 pct)        (+889.4 pct)      (+9.0 pct)  
  EPS             15.32 yen           17.90 yen       162.13 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T